アミロイド性疾患における誤折りのトランス抑制

P Hammarström¹, F Schneider, J W Kelly

¹Department of Chemistry and The Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road BCC265, La Jolla, CA 92037, USA.

Science (New York, N.Y.)

|September 29, 2001

まとめ

トランスチレチン・アミロイドーシスは,突然変異によって引き起こされます. 保護性突然変異はTTRテトラメアを安定させ,解離とアミロイド形成を防止し,この誤折り障害の治療戦略を提供します.

科学分野:

バイオケミストリーバイオケミストリー
遺伝学遺伝学とは
分子生物学は分子生物学である.

背景:

トランスチレチン (TTR) アミロイド疾患は,既知の病原性および病抑制性突然変異を有する誤折り症である.
Val30 --> Met30 (V30M) TTR変異は,家族性アミロイド多神経症の一般的な原因である.
A Thr119 --> Met119 (T119M) 変異は,別々のTTRアレルでV30Mに関連したアミロイドーシスの遺伝抑制剤として作用する.

研究の目的:

T119M TTR変異がV30M誘発のアミロイドーシスを抑制する分子メカニズムを解明する.
混合V30M/T119M TTRテトラメアの安定性に対するT119M TTRサブユニットの影響を調査する.

主な方法:

V30MとT119Mの両方のサブユニットを含む混合TTRテトラメアの生化学分析.
解離に対するテトラメアの安定性の評価.

主要な成果:

V30M TTR テトラメールにT119M TTR サブユニットを組み込むことで,テトラメールの安定性が著しく向上しました.
安定した混合テトラメアは,アミロイド形成の重要なステップである解離の減少を示した.
これらの発見は,アミロイドーシスの観察された内遺伝的トランス抑制の分子基礎を提供します.

結論:

T119M変異はTTRテトラマーを安定させ,解離を阻害し,V30Mキャリアにおけるアミロイド形成を防ぐ.
このメカニズムは,トランスチレチンアミロイドーシスの遺伝的抑制に対する分子的な説明を提供します.
この発見は,TTRテトラメアの安定性を標的とした潜在的な治療戦略を示唆し,アミロイド仮説を支持する.

さらに関連する動画

08:59

Analysis of Protein Folding, Transport, and Degradation in Living Cells by Radioactive Pulse Chase

Published on: February 12, 2019

05:16

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on: May 7, 2020

関連する概念動画

01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...

02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick. Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA molecules by RNA...

02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...

01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...